Identification of prostate cancer risk categories according to surgical margins status, pathological stage and Gleason score

International Journal of Urology

Volumn 20, Issue 11, 2013, Pages 1097-1103

  Schiavina, Riccardo ^a   Borghesi, Marco ^a   Fiorentino, Michelangelo ^a,b   Brunocilla, Eugenio ^a   Manferrari, Fabio ^a   Vagnoni, Valerio ^a   Martorana, Giuseppe ^a  

^a UNIVERSITY OF BOLOGNA   (Italy)

^b HARVARD UNIVERSITY   (United States)

Author keywords

Biochemical relapse; Gleason score; Positive surgical margins; Prostate cancer; Radical prostatectomy

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ADULT; AGED; ARTICLE; BIOCHEMICAL RELAPSE; CANCER RECURRENCE; CANCER RISK; CANCER STAGING; DISEASE FREE SURVIVAL; FOLLOW UP; GLEASON SCORE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; PATHOLOGIST; POSITIVE SURGICAL MARGIN; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATECTOMY; SURGICAL TECHNIQUE;

BIOCHEMICAL RELAPSE; GLEASON SCORE; POSITIVE SURGICAL MARGINS; PROSTATE CANCER; RADICAL PROSTATECTOMY;

HUMANS; ITALY; MALE; PROSTATE; PROSTATIC NEOPLASMS; RETROSPECTIVE STUDIES; RISK ASSESSMENT; SEVERITY OF ILLNESS INDEX;

EID: 84886783820     PISSN: 09198172     EISSN: 14422042     Source Type: Journal    
DOI: 10.1111/iju.12124     Document Type: Article

References (30)

1. Yossepowitch O, Bjartell A, Eastham JA etal. Positive surgical margins in radical prostatectomy: outlining the problem and its long-term consequences. Eur. Urol. 2009; 55: 87-99.
2. Fleshner NE, Evans A, Chadwick K, Lawrentschuk N, Zlotta A. Clinical significance of the positive surgical margin based upon location, grade, and stage. Urol. Oncol. 2010; 28: 197-204.
3. Swindle P, Eastham JA, Ohori M etal. Do margins matter? The prognostic significance of positive surgical margins in radical prostatectomy specimens. J. Urol. 2005; 174: 903-907.
4. Pfitzenmaier J, Pahernik S, Tremmel T, Haferkamp A, Buse S, Hohenfellner M. Positive surgical margins after radical prostatectomy: do they have an impact on biochemical or clinical progression? BJU Int. 2008; 102: 1413-1418.
5. Boorjian SA, Karnes RJ, Crispen PL etal. The impact of positive surgical margins on mortality following radical prostatectomy during the prostate specific antigen era. J. Urol. 2010; 183: 1003-1009.
6. Wright JL, Dalkin BL, True LD etal. Positive surgical margins at radical prostatectomy predict prostate cancer specific mortality. J. Urol. 2010; 183: 2213-2218.
7. Stephenson AJ, Bolla M, Briganti A etal. Postoperative radiation therapy for pathologically advanced prostate cancer after radical prostatectomy. Eur. Urol. 2012; 61: 443-445.
8. Thompson IM, Tangen CM, Paradelo J etal. Adjuvant radiotherapy for pathological T3N0M0 prostate cancer significantly reduces risk of metastases and improves survival: long-term followup of a randomized clinical trial. J. Urol. 2009; 181: 956-962.
9. Thompson IM, Tangen CM, Paradelo J etal. Adjuvant radiotherapy for pathologically advanced prostate cancer: a randomized clinical trial. JAMA 2006; 296: 2329-2335.
10. Bolla M, van Poppel H, Collette L etal. European Organization for Research and Treatment of Cancer. Postoperative radiotherapy after radical prostatectomy: a randomised controlled trial (EORTC trial 22911). Lancet 2005; 366: 572-578.
11. Wiegel T, Bottke D, Steiner U etal. Phase III postoperative adjuvant radiotherapy after radical prostatectomy compared with radical prostatectomy alone in pT3 prostate cancer with postoperative undetectable prostate-specific antigen: ARO 96-02/AUO AP 09/95. J. Clin. Oncol. 2009; 27: 2924-2930.
12. Porter CR, Capitanio U, Perrotte P etal. Adjuvant radiotherapy after radical prostatectomy shows no ability to improve rates of overall and cancer-specific survival in a matched case-control study. BJU Int. 2009; 103: 597-602.
13. Choo R, Hruby G, Hong J etal. Positive resection margin and/or pathologic T3 adenocarcinoma of prostate with undetectable postoperative prostate-specific antigen after radical prostatectomy: to irradiate or not? Int. J. Radiat. Oncol. Biol. Phys. 2002; 52: 674-680.
14. Van der Kwast TH, Bolla M, Van Poppel H etal. Identification of patients with prostate cancer who benefit from immediate postoperative radiotherapy: EORTC 22911. J. Clin. Oncol. 2007; 25: 4178-4186.
15. Ohori M, Kattan MW, Koh H etal. Predicting the presence and side of extracapsular extension: a nomogram for staging prostate cancer. J. Urol. 2004; 171: 1844-1849.
16. Cagiannos I, Karakiewicz P, Eastham JA etal. A preoperative nomogram identifying decreased risk of positive pelvic lymph nodes in patients with prostate cancer. J. Urol. 2003; 170: 1798-1803.
17. Briganti A, Chun FK, Salonia A etal. Validation of a nomogram predicting the probability of lymph node invasion among patients undergoing radical prostatectomy and an extended pelvic lymphadenectomy. Eur. Urol. 2006; 49: 1019-1026.
18. Edge SB, Byrd DR, Compton CC, Fritz AG, Greene FL, Trotti A. AJCC Cancer Staging Manual, 7th edn. Springer, New York, 2010.
19. Shuford MD, Cookson MS, Chang SS etal. Adverse prognostic significance of capsular incision with radical retropubic prostatectomy. J. Urol. 2004; 172: 119-123.
20. Eastham JA, Kuroiwa K, Ohori M etal. Prognostic significance of location of positive margins in radical prostatectomy specimens. Urology 2007; 70: 965-969.
21. Psutka SP, Feldman AS, Rodin D, Olumi AF, Wu CL, McDougal WS. Men with organ-confined prostate cancer and positive surgical margins develop biochemical failure at a similar rate to men with extracapsular extension. Urology 2011; 78: 121-125.
22. Montironi R, Lopez-Beltran A, Scarpelli M, Mazzucchelli R, Cheng L. Handling of radical prostatectomy specimens: total embedding with whole mounts, with special reference to the Ancona experience. Histopathology 2011; 59: 1006-1010.
23. Freedland SJ, Aronson W, Presti JC Jr etal. SEARCH Database Study Group: should a positive surgical margin following radical prostatectomy be pathological stage T2 or T3? Results from the SEARCH database. J. Urol. 2003; 169: 2142-2146.
24. Stephenson AJ, Wood DP, Kattan MW etal. Location, extent and number of positive surgical margins do not improve accuracy of predicting prostate cancer recurrence after radical prostatectomy. J. Urol. 2009; 182: 1357-1363.
25. Budäus L, Isbarn H, Eichelberg C etal. Biochemical recurrence after radical prostatectomy: multiplicative interaction between surgical margin status and pathological stage. J. Urol. 2010; 184: 1341-1346.
26. Barocas DA, Han M, Epstein JI etal. Does capsular incision at radical retropubic prostatectomy affect disease-free survival in otherwise organ-confined prostate cancer? Urology 2001; 58: 746-751.
27. Chuang AY, Nielsen ME, Hernandez DJ, Walsh PC, Epstein JI. The significance of positive surgical margin in areas of capsular incision in otherwise organ confined disease at radical prostatectomy. J. Urol. 2007; 178 (4 Pt 1): 1306-1310.
28. Karakiewicz PI, Eastham JA, Graefen M etal. Prognostic impact of positive surgical margins in surgically treated prostate cancer: multi-institutional assessment of 5831 patients. Urology 2005; 66: 1245-1250.
29. Stephenson AJ, Scardino PT, Kattan MW etal. Predicting the outcome of salvage radiation therapy for recurrent prostate cancer after radical prostatectomy. J. Clin. Oncol. 2007; 25: 2035-2041.
30. MacDonald OK, Schild SE, Vora S etal. Salvage radiotherapy for men with isolated rising PSA or locally palpable recurrence after radical prostatectomy: do outcomes differ? Urology 2004; 64: 760-764.